Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,109 | -22,373 | -90,210 | -69,191 | -39,424 |
| Depreciation Amortization | -1,046 | 236 | 881 | 661 | 439 |
| Income taxes - deferred | 68 | 34 | 141 | 96 | 64 |
| Accounts payable and accrued liabilities | -642 | -814 | 1,149 | 1,959 | 4,171 |
| Other Working Capital | -1,338 | -3,808 | 1,475 | 1,636 | 5,156 |
| Other Operating Activity | 9,090 | 3,927 | 19,174 | 16,765 | 2,219 |
| Operating Cash Flow | $-38,977 | $-22,798 | $-67,390 | $-48,074 | $-27,375 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 50,230 | 8,026 | -37,935 | -85,211 | -62,906 |
| PPE Investments | -42 | -29 | -52 | -8 | N/A |
| Investing Cash Flow | $50,188 | $7,997 | $-37,987 | $-85,219 | $-62,906 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 399 | N/A | 42,295 | 28,433 | 28,413 |
| Other Financing Activity | 0 | 0 | -344 | -344 | -344 |
| Financing Cash Flow | $399 | $N/A | $41,951 | $28,089 | $28,069 |
| Exchange Rate Effect | -40 | -26 | 117 | -138 | -104 |
| Beginning Cash Position | 79,926 | 79,926 | 143,235 | 143,235 | 143,235 |
| End Cash Position | 91,496 | 65,099 | 79,926 | 37,893 | 80,919 |
| Net Cash Flow | $11,570 | $-14,827 | $-63,309 | $-105,342 | $-62,316 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,977 | -22,798 | -67,390 | -48,074 | -27,375 |
| Capital Expenditure | -42 | -29 | -52 | -8 | N/A |
| Free Cash Flow | -39,019 | -22,827 | -67,442 | -48,082 | -27,375 |